中医药
代谢工程
传统医学
工程伦理学
计算机科学
人工智能
工程类
医学
生物
替代医学
病理
生物化学
酶
标识
DOI:10.1051/bioconf/202517403013
摘要
Metabolic engineering serves as a pivotal component in establishing microbial platforms for the effective biosynthesis of expensive compounds, therapeutic agents, and vegetative production systems. This field necessitates thorough comprehension of intracellular biochemical networks (encompassing molecular transformation routes and corresponding catalytic proteins). Nevertheless, the biochemical routes and critical catalysts that control numerous high-value target molecules have not been fully characterized, which is the main bottleneck for the heterologous synthesis of high-value chemicals. To address this limitation, scientists have devised optimized production circuits through the engineering of artificial biocatalysts and de novo biochemical reaction sequences. With the continuous accumulation of biological big data, the data-driven methods of artificial intelligence (AI) technology are promoting the further development of protein and metabolic pathway design. In this paper, we introduce AI-driven machine learning algorithms in prediction models, and also review recent research progress on AI-assisted metabolic engineering design and production of high-value compounds, focusing on how to use AI methods to achieve directed evolution of strains.
科研通智能强力驱动
Strongly Powered by AbleSci AI